5 September 2015 Text size Home About Fermion APIs CMO Contacts Orion Corporation QM EHS PRODUCTION R&D Fermion's history Home / About Fermion We have been manufacturing Active Pharmaceutical Ingredients (API) for both generic and proprietary drug products since 1970. We have also Contract manufacturing services for APIs including oncology and high potent compounds. Our Vision Fermion envisions being an integrated strategic supplier of value-added services and products to pharmaceutical companies by offering technically advanced products. Our Mission Fermion’s competitive advantage lies in its dynamic capabilities to satisfy customer needs by providing competitive services while adhering to current industry regulations. Read more about Fermion and Orion from the brochure. Fermion's History Read more about Fermion's history. Responsible Care Read more about Responsible Care. GMP Certificates List of Inspections Fermion Oy, Koivu-Mankkaan tie 6A, FI-02200 Espoo, Finland TEL. +358 10 4261 FAX: +358 9 452 1764 e-mail: fermionSales@orion.fi Contacts

14 August 2015 Text size Home About Fermion APIs CMO Contacts Orion Corporation Home / News / Arto Toivonen has been appointed as President of Fermion Oy 14 January 2015 Print Arto Toivonen has been appointed as President of Fermion Oy Arto Toivonen has been appointed as President of Fermion Oy, effective January 1, 2015. Arto has worked in Orion since 2006 in the Business Development and Alliance Management Department as a Business Development Director. Before joining Orion Arto worked for Juvantia Pharma Oy as the Vice President of Business Development and a member of Juvantia's management team during 2000-2006. During 1996-2000 he worked in Genencor International B.V. in Leiden, the Netherlands as a Key Account Manager and was responsible for sales of biotechnological products for global customers in several industries. Arto has a Master of Science (Technology) degree in chemical engineering from the University of Technology in Espoo. Arto will report to Liisa Hurme, the Chairman of the Board of Fermion and Senior Vice President, Specialty Products business division. Jorma Mamia will continue as Corporate Security Director as of 1 January 2015. Fermion Oy, Koivu-Mankkaan tie 6A, FI-02200 Espoo, Finland TEL. +358 10 4261 FAX: +358 9 452 1764 e-mail: fermionSales@orion.fi Contacts

13 November 2015 Text size Home About Fermion APIs Contract Manufacturing Contacts News Orion Corporation Products under development Standard Packing sizes Material Safety Data Sheets Home / APIs / Material Safety Data Sheets Print Material Safety Data Sheets Alprazolam Azathioprine Benserazide Buspirone HCI Carbidopa Diltiazem HCI Fluoxetine HCI Flutamide Formoterol fumarate Glipizide Hydroxychloroquine sulfate Irinotecan HCI 6-Mercaptopurine Methotrexate Methotrexate Disodium Nadolol Prazosin HCl Propafenone HCI Quetiapine Fumarate Salmeterol Sodium Cromoglycate Tamsulosin HCI Tolnaftate Trazodone HCI Updated 17 September 2015 Fermion Oy, Koivu-Mankkaan tie 6A, FI-02200 Espoo, Finland TEL. +358 10 4261 FAX: +358 9 452 1764 e-mail: fermionSales@orion.fi Contacts